INMUNE BIO INC. Increase (Decrease) in Other Operating Assets
INMUNE BIO INC. (INMB) reported Increase (Decrease) in Other Operating Assets of -$58.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-06
- INMUNE BIO INC. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$146.00K, a 128.02% decline year-over-year.
- INMUNE BIO INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $88.00K.
- INMUNE BIO INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$151.00K.
- INMUNE BIO INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $176.00K, a 17500.00% increase year-over-year.
- INMUNE BIO INC. increase (decrease) in other operating assets for fiscal 2025 was $516.00K.
- INMUNE BIO INC. increase (decrease) in other operating assets for fiscal 2024 was -$52.00K, a 262.50% decline from fiscal 2023.
- INMUNE BIO INC. increase (decrease) in other operating assets for fiscal 2023 was $32.00K.
- INMUNE BIO INC. increase (decrease) in other operating assets for fiscal 2021 was $99.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$58.00K 10-Q · filed 2026-08-06 | -$209.00K derived: sum of 3 quarters · filed 2026-08-06 | -$33.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $88.00K 10-Q · filed 2026-05-07 | -$63.00K derived: sum of 2 quarters · filed 2026-05-07 | $113.00K derived: sum of 3 quarters · filed 2026-05-07 | $634.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $25.00K derived: sum of 2 quarters · filed 2026-03-30 | $546.00K derived: sum of 3 quarters · filed 2026-08-06 | $516.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $697.00K derived: sum of 2 quarters · filed 2026-08-06 | $667.00K 10-Q · filed 2025-10-30 | $664.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $521.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $491.00K 10-Q · filed 2026-08-06 | $488.00K derived: sum of 3 quarters · filed 2026-08-06 | $489.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$30.00K 10-Q · filed 2026-05-07 | -$33.00K derived: sum of 2 quarters · filed 2026-05-07 | -$32.00K derived: sum of 3 quarters · filed 2026-05-07 | -$57.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$2.00K derived: sum of 2 quarters · filed 2026-03-30 | -$27.00K derived: sum of 3 quarters · filed 2026-03-30 | -$52.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$24.00K derived: sum of 2 quarters · filed 2025-10-30 | -$49.00K 10-Q · filed 2025-10-30 | -$47.00K derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$50.00K 10-Q · filed 2025-08-07 | -$48.00K derived: sum of 3 quarters · filed 2025-08-07 | -$49.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$25.00K 10-Q · filed 2025-05-08 | -$23.00K derived: sum of 2 quarters · filed 2025-05-08 | -$24.00K derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.00K derived: sum of 2 quarters · filed 2025-03-27 | $32.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $30.00K 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | $31.00K 10-Q · filed 2024-08-01 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $99.00K 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $99.00K 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |